Seattle Cancer Care Alliance, Site #100 — Seattle, Washington

Seattle Cancer Care Alliance, Site #100 is a clinical research site located in Seattle, Washington, United States 98109.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Seattle Cancer Care Alliance, Site #100 has participated in 2 clinical trials.

Therapeutic areas: Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL), Chronic Myeloid Leukemia.

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Seattle Cancer Care Alliance, Site #100?

Seattle Cancer Care Alliance, Site #100 has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Seattle Cancer Care Alliance, Site #100 conducted?

Seattle Cancer Care Alliance, Site #100 has 2 clinical trials on record. Their work covers Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL), Chronic Myeloid Leukemia.

Is Seattle Cancer Care Alliance, Site #100 accredited by Crixeo Health?

Seattle Cancer Care Alliance, Site #100 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Seattle Cancer Care Alliance, Site #100?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.